Article
Small Molecule Agonists of TREM2 Reprogram Microglia and Protect Synapses in Human Alzheimer’s Models
2026-01-21
Abstract excerpt
Triggering receptor expressed on myeloid cells-2 (TREM2) is a key immune receptor in the central nervous system that regulates microglial phagocytosis, survival, and neuroinflammatory responses. TRME2 variants have been established as genetic risk factors for Alzheimer’s disease (AD). However, the therapeutic development of TREM2 modulators has been limited to antibody-based approaches that face limitations in blo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2df9b54-80a3-5696-b9a8-3b3f3f1f0c6f
- DOI
- 10.64898/2026.01.19.700278
